Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; The University of Edinburgh, Edinburgh, United Kingdom.
The University of Edinburgh, Edinburgh, United Kingdom.
J Arthroplasty. 2024 Feb;39(2):559-567. doi: 10.1016/j.arth.2023.08.016. Epub 2023 Aug 10.
Total knee arthroplasty allows immediate postoperative weight-bearing and is increasingly recognized as a suitable treatment option for older patients who have tibial plateau fractures (TPFs). This systematic review evaluated the clinical and functional outcomes associated with primary versus secondary TKA for the treatment of TPFs in patients aged ≥55 years.
Various databases were searched from inception to December 2021. Studies investigating outcomes of primary TKA (pTKA) as the initial treatment for TPFs in patients of mean age ≥55 years or those investigating outcomes of secondary TKA (sTKA) following any other primary treatment for TPFs were included. Quality of included studies was assessed using a methodological scale. Of 767 potentially relevant studies, 12 studies comprising 341 patients were included: 121 patients underwent (pTKA) and 220 patients underwent sTKA. There were 3 high-quality studies. Patients in the sTKA cohort were significantly younger at the time of TKA compared with those undergoing pTKA (mean 61.3 versus 72.2 years, P < .001, 95% confidence interval (CI) 8.2 to 13.6).
Intraoperative and postoperative complication rates were lower with pTKA; in particular, sTKA was associated with a significantly increased rate of stiffness requiring reintervention and patella tendon rupture. Functional outcome was greater after pTKA, but this did not reach statistical significance (85.2 versus 79.9%, P = .359, 95% CI -16.7 to 6.1).
Primary TKA was associated with lower complication rates than secondary TKA after TPF. In appropriate cases of TPF in older adults, it may be preferable to proceed with TKA as primary treatment rather than delaying until after fracture union or malunion.
全膝关节置换术允许术后立即负重,并且越来越被认为是治疗≥55 岁胫骨平台骨折(TPF)患者的合适治疗选择。本系统评价评估了原发性与继发性 TKA 治疗 TPF 的临床和功能结局,纳入的患者平均年龄≥55 岁。
从建库到 2021 年 12 月,检索了各种数据库。纳入的研究包括:平均年龄≥55 岁的 TPF 患者初次行 TKA(pTKA)作为初始治疗,或任何其他 TPF 初次治疗后继发行 TKA(sTKA)的研究。使用方法学量表评估纳入研究的质量。在 767 篇潜在相关研究中,纳入了 12 项研究共 341 例患者:121 例行 pTKA,220 例行 sTKA。其中有 3 项高质量研究。与 pTKA 组相比,sTKA 组 TKA 时年龄明显更小(平均 61.3 岁 vs 72.2 岁,P<.001,95%置信区间[CI] 8.2 至 13.6)。
pTKA 的术中及术后并发症发生率较低;特别是,sTKA 与显著增加的僵硬发生率及髌腱断裂相关,需要再次干预。pTKA 后的功能结局更好,但未达到统计学意义(85.2% vs 79.9%,P=.359,95%CI -16.7 至 6.1)。
与 TPF 后行 sTKA 相比,pTKA 后并发症发生率较低。对于老年 TPF 患者,如果情况合适,可能更倾向于将 TKA 作为初次治疗,而不是延迟到骨折愈合或畸形愈合后再进行。